1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Automation in Biopharmaceutical Revenue
• 1.4 Market by Type
  • 1.4.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Clinical Stage Automation
  • 1.4.3 Drug Discovery Stage Automation
• 1.5 Market by Application
  • 1.5.1 Global Automation in Biopharmaceutical Market Share by Application: 2020 VS 2026
  • 1.5.2 Research and Development
  • 1.5.3 Clinical
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Automation in Biopharmaceutical Market Perspective (2015-2026)
• 2.2 Global Automation in Biopharmaceutical Growth Trends by Regions
  • 2.2.1 Automation in Biopharmaceutical Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Automation in Biopharmaceutical Historic Market Share by Regions (2015-2020)
  • 2.2.3 Automation in Biopharmaceutical Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Automation in Biopharmaceutical Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Automation in Biopharmaceutical Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Automation in Biopharmaceutical Players by Market Size
  • 3.1.1 Global Top Automation in Biopharmaceutical Players by Revenue (2015-2020)
  • 3.1.2 Global Automation in Biopharmaceutical Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Automation in Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Automation in Biopharmaceutical Market Concentration Ratio
  • 3.2.1 Global Automation in Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Automation in Biopharmaceutical Revenue in 2019
• 3.3 Automation in Biopharmaceutical Key Players Head office and Area Served
• 3.4 Key Players Automation in Biopharmaceutical Product Solution and Service
• 3.5 Date of Enter into Automation in Biopharmaceutical Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Automation in Biopharmaceutical Historic Market Size by Type (2015-2020)
• 4.2 Global Automation in Biopharmaceutical Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Automation in Biopharmaceutical Market Size by Application (2015-2020)
• 5.2 Global Automation in Biopharmaceutical Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Automation in Biopharmaceutical Market Size (2015-2020)
• 6.2 Automation in Biopharmaceutical Key Players in North America (2019-2020)
• 6.3 North America Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 6.4 North America Automation in Biopharmaceutical Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Automation in Biopharmaceutical Market Size (2015-2020)
• 7.2 Automation in Biopharmaceutical Key Players in Europe (2019-2020)
• 7.3 Europe Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 7.4 Europe Automation in Biopharmaceutical Market Size by Application (2015-2020)

8 China

• 8.1 China Automation in Biopharmaceutical Market Size (2015-2020)
• 8.2 Automation in Biopharmaceutical Key Players in China (2019-2020)
• 8.3 China Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 8.4 China Automation in Biopharmaceutical Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Automation in Biopharmaceutical Market Size (2015-2020)
• 9.2 Automation in Biopharmaceutical Key Players in Japan (2019-2020)
• 9.3 Japan Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 9.4 Japan Automation in Biopharmaceutical Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Automation in Biopharmaceutical Market Size (2015-2020)
• 10.2 Automation in Biopharmaceutical Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 10.4 Southeast Asia Automation in Biopharmaceutical Market Size by Application (2015-2020)

11 India

• 11.1 India Automation in Biopharmaceutical Market Size (2015-2020)
• 11.2 Automation in Biopharmaceutical Key Players in India (2019-2020)
• 11.3 India Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 11.4 India Automation in Biopharmaceutical Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Automation in Biopharmaceutical Market Size (2015-2020)
• 12.2 Automation in Biopharmaceutical Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 12.4 Central & South America Automation in Biopharmaceutical Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Danaher
  • 13.1.1 Danaher Company Details
  • 13.1.2 Danaher Business Overview
  • 13.1.3 Danaher Automation in Biopharmaceutical Introduction
  • 13.1.4 Danaher Revenue in Automation in Biopharmaceutical Business (2015-2020))
  • 13.1.5 Danaher Recent Development
• 13.2 GE
  • 13.2.1 GE Company Details
  • 13.2.2 GE Business Overview
  • 13.2.3 GE Automation in Biopharmaceutical Introduction
  • 13.2.4 GE Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.2.5 GE Recent Development
• 13.3 PerkinElmer
  • 13.3.1 PerkinElmer Company Details
  • 13.3.2 PerkinElmer Business Overview
  • 13.3.3 PerkinElmer Automation in Biopharmaceutical Introduction
  • 13.3.4 PerkinElmer Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.3.5 PerkinElmer Recent Development
• 13.4 Tecan Trading
  • 13.4.1 Tecan Trading Company Details
  • 13.4.2 Tecan Trading Business Overview
  • 13.4.3 Tecan Trading Automation in Biopharmaceutical Introduction
  • 13.4.4 Tecan Trading Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.4.5 Tecan Trading Recent Development
• 13.5 Thermo Fisher Scientific
  • 13.5.1 Thermo Fisher Scientific Company Details
  • 13.5.2 Thermo Fisher Scientific Business Overview
  • 13.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Introduction
  • 13.5.4 Thermo Fisher Scientific Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.5.5 Thermo Fisher Scientific Recent Development
• 13.6 Bruker
  • 13.6.1 Bruker Company Details
  • 13.6.2 Bruker Business Overview
  • 13.6.3 Bruker Automation in Biopharmaceutical Introduction
  • 13.6.4 Bruker Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.6.5 Bruker Recent Development
• 13.7 Peak Analysis and Automation
  • 13.7.1 Peak Analysis and Automation Company Details
  • 13.7.2 Peak Analysis and Automation Business Overview
  • 13.7.3 Peak Analysis and Automation Automation in Biopharmaceutical Introduction
  • 13.7.4 Peak Analysis and Automation Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.7.5 Peak Analysis and Automation Recent Development
• 13.8 Waters
  • 13.8.1 Waters Company Details
  • 13.8.2 Waters Business Overview
  • 13.8.3 Waters Automation in Biopharmaceutical Introduction
  • 13.8.4 Waters Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.8.5 Waters Recent Development
• 13.9 Capsugel
  • 13.9.1 Capsugel Company Details
  • 13.9.2 Capsugel Business Overview
  • 13.9.3 Capsugel Automation in Biopharmaceutical Introduction
  • 13.9.4 Capsugel Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.9.5 Capsugel Recent Development
• 13.10 RheoSense
  • 13.10.1 RheoSense Company Details
  • 13.10.2 RheoSense Business Overview
  • 13.10.3 RheoSense Automation in Biopharmaceutical Introduction
  • 13.10.4 RheoSense Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.10.5 RheoSense Recent Development
• 13.11 Eirechrom
  • 10.11.1 Eirechrom Company Details
  • 10.11.2 Eirechrom Business Overview
  • 10.11.3 Eirechrom Automation in Biopharmaceutical Introduction
  • 10.11.4 Eirechrom Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 10.11.5 Eirechrom Recent Development
• 13.12 BioProcess International
  • 10.12.1 BioProcess International Company Details
  • 10.12.2 BioProcess International Business Overview
  • 10.12.3 BioProcess International Automation in Biopharmaceutical Introduction
  • 10.12.4 BioProcess International Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 10.12.5 BioProcess International Recent Development
• 13.13 Novasep
  • 10.13.1 Novasep Company Details
  • 10.13.2 Novasep Business Overview
  • 10.13.3 Novasep Automation in Biopharmaceutical Introduction
  • 10.13.4 Novasep Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 10.13.5 Novasep Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Automation in Biopharmaceutical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Automation in Biopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis and Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep

Market segment by Type, the product can be split into
Clinical Stage Automation
Drug Discovery Stage Automation
Market segment by Application, split into
Research and Development
Clinical

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America